← Open Payments lookup

GRACE DUGGAN: Open Payments

NPI 1346012895 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$932 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $116 · 2025 $932

Food & beverage: $932
CompanyPaymentsAmount
Amgen Inc.6$179
Impulse Dynamics (USA) Inc.2$173
Takeda Pharmaceuticals U.S.A., Inc.3$166
Novartis Pharmaceuticals Corporation5$137
Bayer Healthcare Pharmaceuticals Inc.1$125
Edwards Lifesciences Corporation1$50
United Therapeutics Corporation1$25
AstraZeneca Pharmaceuticals LP1$22
CVRx, Inc.1$21
AtriCure, Inc.1$20

Products named: Optimizer, LIVTENCITY, Repatha, LEQVIO, Kerendia, PASCAL, TYVASO, Barostim Neo System.

Industry payments across TX — which companies pay providers there.